Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane Administration Strategies in CABG
NCT04238806Completed
- Sponsor
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
- Start
- Sep 2013
- Primary completion
- Aug 2014
- Modality
- Allosteric Modulators
01
Overview
Randomised, double-blind trial of desflurane in coronary artery disease (CAD) (2 arms), sponsored by Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Primary endpoint: Serum Brain Natriuretic Peptide Levels. Started Sep 2013; status: completed.
02
Drugs
desflurane
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04238806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238806.